PTEN and glioma: As a result of the drug screening, six compounds that significantly enhanced the anti-glioma effect of BKM120 in the PTEN-deficient GBM cell line were successfully identified, and the MTH1 inhibitor TH588, which had the highest SI score in the screen, was further studied.